You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Drug Therapy, Other

Citations 121-130 of 211 total displayed.

Past content (since Nov 1998):

Studies
Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis: Results of a Randomized, Placebo-Controlled, Phase 2 Trial
Alexa B. Kimball; Kenneth B. Gordon; Richard G. Langley; Alan Menter; Elliot K. Chartash; Joaquin Valdes; for the ABT-874 Psoriasis Study Investigators
Arch Dermatol 2008; 144: 200-207. [Abstract] [Full text] [PDF]  

Studies
Multicenter Randomized, Double-blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris
Victoria P. Werth; David Fivenson; Amit G. Pandya; Diana Chen; M. Joyce Rico; Joerg Albrecht; David Jacobus
Arch Dermatol 2008; 144: 25-32. [Abstract] [Full text] [PDF]  

Observations
A Retrospective Case Series Review of the Peroxisome Proliferator-Activated Receptor Ligand Rosiglitazone in the Treatment of Atopic Dermatitis
Ramona Behshad; Kevin D. Cooper; Neil J. Korman
Arch Dermatol 2008; 144: 84-88. [Abstract] [Full text] [PDF]  

Editorials
Treatment of Pemphigus: The Need for More Evidence
Linda K. Martin; Dedee F. Murrell
Arch Dermatol 2008; 144: 100-101. [Extract] [Full text] [PDF]  

Correspondence
Successful Treatment of Necrobiosis Lipoidica With Antimalarial Agents
François Durupt; Stéphane Dalle; Sébastien Debarbieux; Brigitte Balme; Sandra Ronger; Luc Thomas
Arch Dermatol 2008; 144: 118-119. [Extract] [Full text] [PDF]  

Evidence-Based Dermatology: Research Commentaries
Level of Agreement With the British Guidelines for the Use of Biological Therapies for Psoriasis
Tamar Nijsten
Arch Dermatol 2007; 143: 1567-1569. [Extract] [Full text] [PDF]  

Research Letters
Quality of Dermatologic Care Delivered by Physician Assistants: An Analysis of Prescribing Behavior for the Combination Antifungal Agent Clotrimazole-Betamethasone
Anita Satyaprakash; Rajesh Balkrishnan; Fabian T. Camacho; Sujata S. Jayawant; Alan B. Fleischer Jr; Steven R. Feldman
Arch Dermatol 2007; 143: 1591-a-1592-a. [Extract] [Full text] [PDF]  

Correspondence
British Guidelines on the Use of Biological Therapies for Psoriasis: A Note of Clarification on the Role of Etanercept
Catherine H. Smith; Anthony D. Ormerod
Arch Dermatol 2007; 143: 1595-a-1596-a. [Extract] [Full text] [PDF]  

Correspondence
Clinical Improvement of Pityriasis Rubra Pilaris With Combination Etanercept and Acitretin Therapy
Kristy F. Davis; Jashin J. Wu; Jenny E. Murase; Fredric R. Rosenberg; Erik P. Sorenson; Azin Meshkinpour
Arch Dermatol 2007; 143: 1597-1599. [Extract] [Full text] [PDF]  

Correspondence
Docetaxel Monotherapy for Angiosarcoma in an Elderly Patient
Tohru Nagano; Yukimasa Tai; Yuka Higashida; Norihiro Fujiwara; Masahiro Oka; Chikako Nishigori
Arch Dermatol 2007; 143: 1602-1603. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Drug Therapy, Other
 collections from JAMA & Archives Journals.
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.